New radiation therapy aims to control Hard-to-Treat prostate cancer
NCT ID NCT05570994
First seen Jan 10, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This study tests a new treatment called 177Lu-HTK03170 for men with a type of advanced prostate cancer that has stopped responding to hormone therapy. The treatment delivers radiation directly to cancer cells using a targeting molecule. The goal is to find a safe dose and see if it can shrink tumors or slow the disease. About 50 men will take part and be followed for up to 2 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BC Cancer
Vancouver, British Columbia, V5Z 4E6, Canada
Conditions
Explore the condition pages connected to this study.